OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)
Clinical trial NCT05139810 · COMPLETED
Trial details
- NCT number
- NCT05139810
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-11-09
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.